Major Depressive Disorder Clinical Trial
Official title:
Deep Brain Stimulation in Patients With Chronic Treatment Resistant Depression
Major depressive disorders are real public health issues in terms of diagnosis and treatment.
Some forms of depression are chronic and resistant to treatment (TRD). In these forms suicide
risk is important.
Patients with TRD are potential candidates for neurosurgical interventions to treat
depression. However, psychosurgery interventions based upon lesions, showed their limitations
related to 1. the large variability in neurosurgical gestures, 2. their side effects, and of
course 3. the irreversible damage caused by the surgery.
Thus, deep brain stimulation (DBS) could represent an opportunity for patients suffering from
TRD. Our preliminary study based upon the stimulation of the accumbens nucleus showed
encouraging results. The investigators have thus planned a randomized controlled trial versus
sham stimulation to confirm the therapeutic value of nucleus accumbens DBS.
Because of their recurrent nature, their prevalence and their consequences, major depressive
disorders are real public health issues in terms of diagnosis and treatment.
Some forms of depression are chronic and resistant to treatment (TRD), either unipolar
(repeated episodes of depression) or bipolar (repeated episodes of depression and manic
and/or hypomanic episodes). In these forms suicide risk is important.
Patients with TRD are potential candidates for neurosurgical interventions to treat
depression. The benefit of neurosurgical procedures is expected to be important in these
patients.
Psychosurgery interventions based upon lesions, however, showed their limitations related to
1/ the large variability in neurosurgical gestures, 2/ their side effects, and of course 3/
the irreversible damage caused by the surgery.
Current brain imaging data yielded fresh information about the pathophysiology of depression
and suggested new therapeutic approaches in TRD.
Modulation of sub-caudate specific pathways, which are part of orbitofrontal and anterior
cingulate cortico-subcortical loops should allow for a diminution of depressive symptoms.
The modulation of these specific pathways, initially targeted by classical neurosurgery,
could benefit from current developments in functional neurosurgery.
Deep brain stimulation (DBS) may represent an opportunity for patients suffering from TRD.
Our preliminary study based upon the stimulation of the accumbens nucleus showed encouraging
results. The investigators have thus planned a randomized controlled trial versus sham
stimulation to confirm the therapeutic value of nucleus accumbens DBS.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05537558 -
Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT)
|
||
| Terminated |
NCT02192099 -
Open Label Extension for GLYX13-C-202, NCT01684163
|
Phase 2 | |
| Completed |
NCT03142919 -
Lipopolysaccharide (LPS) Challenge in Depression
|
Phase 2 | |
| Recruiting |
NCT05547035 -
Identification of Physiological Data by a Wearable Monitor in Subjects Suffering From Major Depression Disorders
|
N/A | |
| Terminated |
NCT02940769 -
Neurobiological Effects of Light on MDD
|
N/A | |
| Recruiting |
NCT05892744 -
Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression
|
Phase 4 | |
| Recruiting |
NCT05537584 -
SMART Trial to Predict Anhedonia Response to Antidepressant Treatment
|
Phase 4 | |
| Active, not recruiting |
NCT05061706 -
Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
|
Phase 3 | |
| Completed |
NCT04479852 -
A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder
|
Phase 2 | |
| Recruiting |
NCT04032301 -
Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans
|
Phase 1 | |
| Recruiting |
NCT05527951 -
Enhanced Measurement-Based Care Effectiveness for Depression (EMBED) Study
|
N/A | |
| Completed |
NCT03511599 -
Cycloserine rTMS Plasticity Augmentation in Depression
|
Phase 1 | |
| Recruiting |
NCT04392947 -
Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation
|
N/A | |
| Recruiting |
NCT05895747 -
5-HTP and Creatine for Depression R33 Phase
|
Phase 2 | |
| Recruiting |
NCT05273996 -
Predictors of Cognitive Outcomes in Geriatric Depression
|
Phase 4 | |
| Recruiting |
NCT05813093 -
Interleaved TMS-fMRI in Ultra-treatment Resistant Depression
|
N/A | |
| Recruiting |
NCT05135897 -
The Neurobiological Fundaments of Depression and Its Relief Through Neurostimulation Treatments
|
||
| Enrolling by invitation |
NCT04509102 -
Psychostimulant Augmentation of Repetitive TMS for the Treatment of Major Depressive Disorder
|
Early Phase 1 | |
| Recruiting |
NCT06026917 -
Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)
|
Phase 4 | |
| Recruiting |
NCT06145594 -
EMA-Guided Maintenance TMS for Depression
|
N/A |